Lowering the Cost of Healthcare: Technology’s Role in Driving Affordability

Health Care Costs and Drug PricingHouse Oversight and Government Reform Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs · 2025-12-10 · 119th Congress
This joint hearing of the House Oversight Subcommittees on Economic Growth, Energy Policy, and Regulatory Affairs and on Health Care and Financial Services examined whether technologies such as artificial intelligence, price transparency tools, and payment-smoothing software could reduce U.S. Begins at 0:18:20
Transcript
Highlights

Title

Health technology's potential to lower health care costs

Purpose

This joint hearing of the House Oversight Subcommittees on Economic Growth, Energy Policy, and Regulatory Affairs and on Health Care and Financial Services examined whether technologies such as artificial intelligence, price transparency tools, and payment-smoothing software could reduce U.S. health care costs. The hearing occurred amid a partisan dispute over the impending expiration of enhanced ACA premium tax credits, with Democrats arguing the topic distracted from that immediate crisis and Republicans framing the ACA itself as a driver of high costs. Begins at0:18:20

Who spoke

Chairman Burlison0:18:20: Opened the joint hearing, argued Biden-era regulations and the Inflation Reduction Act worsened health costs0:19:05, and touted AI, wearables, 3D printing, and telehealth as cost-lowering tools0:20:30; in closing announced he is introducing the "MAHA Act" to create portable tax-free health wallets and encourage price posting2:07:48.

Ranking Member Maxwell Frost (D-FL)0:22:09: Said 189,000 people in his district will see premiums rise 50–300% when ACA tax credits expire in five weeks0:22:38, called holding this hearing now "an insult" to 25 million affected Americans0:23:04, and later pressed witness Brian Whorley on why his payment-smoothing company is needed as a witness on "affordability"1:08:56.

Chairman Glenn Grothman (R-WI)0:27:45: Argued insurance companies are the main beneficiaries of the ACA and the government must spend $34 billion a year more to prop it up0:28:10, cited health spending near $5 trillion (18% of GDP) and roughly one-third of spending as wasteful ($1.6 trillion in 2023)0:29:31, and led questioning on administrative waste and utilization variation1:13:22.

Ranking Member Raja Krishnamoorthi (D-IL)0:31:59: Said half a million Illinoisans would see premiums jump from $260 to $464/month if credits expire0:31:59 and detailed threatened closures at Loretto and Franklin hospitals0:33:06; later pressed on AI chatbot harms and White House efforts to preempt state AI guardrails1:26:28.

Brian Whorley, CEO, Paytient Technologies0:36:46: Described Paytient's model of transactable cash pricing and payment smoothing, serving 6,000 employers and powering the Medicare Prescription Payment Plan for nearly 22 million beneficiaries0:37:47; proposed automatic senior enrollment in the plan and expanding smoothing to medical costs and ACA/employer plans0:39:34.

Dr. Darius Lakdawalla, USC Schaeffer Center0:41:50: Cited the 11-year U.S. delay in approving propranolol despite proven stroke and heart-attack risk reduction0:42:14; called for reforming Medicare's Coverage with Evidence Development program and Medicare Advantage risk adjustment, and said opaque pricing lets sellers "exploit" buyer blindness0:45:41.

Dr. Zaid Obermeyer, UC Berkeley0:46:40: Described an AI tool predicting sudden cardiac death risk to reduce unnecessary defibrillator implants (two-thirds never fire)0:48:02; urged faster federal health data access, modernized FDA evaluation of AI, and CMS payment codes for AI shown to improve outcomes0:50:42.

Chris Jacobs, Founder, Juniper Research Group0:51:29: Argued the ACA failed to meet Obama's promised $2,500 premium cut and premiums more than doubled in its first four years0:51:53; said the medical loss ratio provision encouraged insurer consolidation into PBMs0:52:44 and cited a $2.2 billion cost from the 340B program's premium effects0:53:28; recommended letting enhanced subsidies expire, citing fraud concerns and a recent GAO report1:42:14.

Sophia Tripoli, Families USA0:55:08: Called the U.S. health system a "full-on affordability crisis" driven by corporate consolidation among insurers, drug makers, and hospitals0:56:27; urged extending enhanced premium tax credits, enacting site-neutral payments, and letting Medicare negotiate more drug prices0:58:55.

Rep. Bell (D-MO)1:46:52: Compared the ACA's evolution to Social Security's gradual improvement, noted 95% of Missouri marketplace enrollees rely on premium tax credits1:46:52, and recounted Republicans' repeated repeal attempts since 2010 without offering alternatives1:49:00.

Rep. Gill (R-TX)1:52:49: Argued health care's $5 trillion scale makes it incomparable to Social Security1:52:49 and had Jacobs confirm ACA premiums doubled in four years and that enhanced subsidies are "inherently inflationary"1:57:30.

Rep. Simon (D-CA)1:58:26: Shared her husband's terminal T-cell prolymphocytic leukemia diagnosis and resulting medical debt despite insurance1:58:57, and highlighted UC Berkeley CRISPR lab research on sickle cell treatment, noting Trump administration funding cuts to the lab2:01:56.

A committee member (Maguire)1:27:26: Credited tariffs and increased drilling for falling gas prices1:27:56 and argued certificate-of-need laws block free-market competition that could lower costs, citing an MRI clinic example1:30:20.

A committee member (Randall)1:33:41: Cautioned against letting ACA tax credits expire while critiquing the system, cited Washington State's all-payer claims database for price transparency1:37:21, and pressed Dr. Obermeyer on oversight of the "Wiser" AI model in Medicare claims1:38:15.

A committee member (Donaldson)1:39:38: Argued the ACA's original design aimed at single-payer health care1:40:26 and questioned Jacobs on a reported case of a single Social Security number linked to over 26,000 days of subsidized coverage across 125 policies in 20231:41:22.

Key moments

Grothman stated nearly one-third of U.S. health spending—about $1.6 trillion in 2023—is wasteful and does not improve patient outcomes, comparable to total federal spending on Medicare, Medicaid, CHIP, and ACA subsidies that year0:29:31.

Frost and Krishnamoorthi both cited that letting enhanced ACA premium tax credits expire in five weeks would raise premiums 50–300% for roughly 25 million Americans, including 189,000 in Frost's district0:22:380:24:12.

Obermeyer testified two-thirds of implanted defibrillators never fire because doctors misjudge risk, and described an AI tool using ECG data to better predict sudden cardiac death risk, working with Providence Saint Patrick's Hospital in Missoula, Montana0:48:020:48:28.

Jacobs stated individual market premiums more than doubled in the ACA's first four years despite Obama's promised $2,500 reduction, and that a GAO report found one Social Security number tied to over 26,000 days of subsidized coverage across 125 policies in 20230:51:531:41:22.

Frost confronted witness Brian Whorley, arguing rising demand for Paytient's payment-smoothing product itself demonstrates Congress is failing to make health care affordable, saying "if you have to buy now, pay later, you can't afford it"1:09:25.

Bell contrasted Social Security's historical exclusions with its bipartisan improvement over decades, challenging Republicans to work toward improving rather than repealing the ACA, noting no GOP replacement plan has passed since 2011 repeal votes began1:49:00.

Lakdawalla and Obermeyer both cited data-access and disclosure problems: Lakdawalla said opaque billing lets intermediaries profit from "confusion"0:46:10, while Obermeyer said it took him ten years to get U.S. health data for research he ultimately completed faster in Sweden0:48:55.

Simon disclosed her husband's death from a rare leukemia and the medical debt left behind despite insurance coverage, tying the story to the stakes of the looming premium-credit expiration1:58:571:59:46.

Jacobs and Tripoli found rare bipartisan agreement on site-neutral Medicare payments and hospital price disclosure as needed reforms, even as they disagreed on extending premium subsidies1:54:041:19:33.

Krishnamoorthi noted the Trump administration is pursuing federal preemption of state AI guardrails (such as Illinois's ban on AI psychotherapy chatbots), which Obermeyer's own testimony did not endorse or mention1:26:281:26:54.

Metadata

CommitteeHouse Oversight and Government Reform Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs
Chamber / CongressHouse · 119th Congress
Date2025-12-10
TypeHearing
Witnesses
Mr. Brian Whorley — Chief Executive Officer, Paytient Technologies, Inc.
Dr. Darius Lakdawalla — Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, University of Southern California
Dr. Zaid Obermeyer — Blue Cross of California Distinguished Associate Professor/Health Policy and Management, University of California-Berkeley
Mr. Chris Jacobs — Founder, Juniper Research Group
Ms. Sophia Tripoli — Senior Director, Health Policy, Families USA
Videoyoutube
Transcript262 caption blocks · 19,097 words · 2:12:03 runtime
EventCongress.gov 118736